论文部分内容阅读
目的:针对血糖控制水平对ICU危重症患者而近期预后的影响进行研究分析。方法:本次的研究对象选取本院自2013年1月~2014年1月这一期间160例合并应激性高血糖的ICU危重症患者,根据患者的每日早晨空腹血糖的平均值将其分为三组,其中血糖≤6.1mmol/L的一组为1组,血糖在6.1~10.0mmol/L之间的一组为2组,血糖≥10.0mmol/L的一组为3组。对三组患者的临床资料进行回顾性分析。结果:在ICU住院日、院内感染发生率、呼吸机带机时间以及多器官功能衰竭综合征的发生率的对比中,1组患者明显低于3组患者,两组患者对比差异具有统计学意义(P<0.05),但是两组患者的死亡率对比差异无统计学意义(P>0.05)。1组ICU住院时间和呼吸机带机时间短于2组,两组对比(P<0.05),但是在低血糖的发生率和死亡率的对比中,1组患者明显高于2组患者,两组患者对比差异具有统计学意义(P<0.05)。结论:针对ICU危重症患者合并应激性高血糖时对其进行积极的血糖控制可以减少并发症的发生,但是在控制血糖的同时要注意血糖控制水平,避免患者发生低血糖的情况。
Objective: To study the effect of blood glucose control on the recent prognosis of critically ill patients with ICU. Methods: This study selected 160 patients with ICU critically ill patients with stress hyperglycemia in our hospital from January 2013 to January 2014, and according to the daily average fasting blood glucose Divided into three groups, including a group of blood glucose ≤ 6.1mmol / L as a group, a group of blood glucose between 6.1 ~ 10.0mmol / L for the two groups, a group of glucose ≥ 10.0mmol / L for the three groups. The clinical data of three groups were retrospectively analyzed. Results: In the ICU hospitalization days, the incidence of nosocomial infections, ventilator-machine time and the incidence of multiple organ failure syndrome, one group was significantly lower than the three groups, the difference between the two groups was statistically significant (P <0.05), but there was no significant difference in mortality between the two groups (P> 0.05). The ICU length of hospital stay and ventilator machine time in group 1 were shorter than that in group 2 (P <0.05), but in the comparison between the incidence of hypoglycemia and mortality, patients in group 1 were significantly higher than those in group 2 The differences between the two groups were statistically significant (P <0.05). CONCLUSIONS: In the ICU critically ill patients with stress hyperglycemia when its active glycemic control can reduce the incidence of complications, but in the control of blood glucose should pay attention to the level of blood glucose control, to avoid the occurrence of hypoglycemia in patients.